Low-dose steroid treatment for dialysis-related amyloid arthropathy
暂无分享,去创建一个
[1] T. Miyata,et al. Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. , 1997, Journal of the American Society of Nephrology : JASN.
[2] N. Taniguchi,et al. beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. , 1993, The Journal of clinical investigation.
[3] K. Honda,et al. β2‐Microglobulin Amyloidosis in Hemodialysis Patients An Autopsy Study of Intervertebral Disks and Posterior Longitudinal Ligaments , 1990, Acta pathologica japonica.
[4] F. Gejyo,et al. Dialysis amyloidosis: current disease concepts and new perspectives for its treatment. , 1990, Contributions to nephrology.
[5] B. Descamps-Latscha,et al. Short-term administration of colchicine to haemodialysis patients: plasma beta-2-microglobulin and phagocyte oxidative response. , 1990, Nephron.